Sign inJoin waitlistJoin the waitlist

KM

Kristi McIntyre

Physician · Texas Oncology

Credentials: · · · ·

History

Texas Oncology
Present

Mayo Clinic College of Medicine and Science
1988–1989
Gastroenterology
University of Mississippi Medical Center
1986–1988
University of Mississippi Medical Center
1985–1986
Internal Medicine
1982–1985
Tulane University School of Medicine
1978–1982

Research

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised,…
The Lancet Oncology · 2018 · 622 citations
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
Journal of Clinical Oncology · 2009 · 435 citations
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
Journal of Clinical Oncology · 2006 · 414 citations

JO
Joyce O'Shaughnessy
19 papers
SV
Svetislava Vukelja
8 papers
FH
Frankie Holmes
7 papers
JB
Joanne Blum
7 papers
JP
John Pippen
6 papers
SW
Sharon Wilks
5 papers
CO
Cynthia Osborne
4 papers
DP
Devchand Paul
4 papers
DR
Donald Richards
4 papers
DL
Deborah Lindquist
3 papers
JS
John Sandbach
3 papers
LK
Lea Krekow
3 papers

Clinical trials

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Site PI · Recruiting
Agendia
2017–2037